---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-068985"
form_type: "8-K"
ticker: "HOTH"
cik: "0001711786"
company_name: "Hoth Therapeutics, Inc."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T09:30:21.103684+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Hoth Therapeutics issues 2M shares of Series B Preferred with 10-to-1 voting for $1,000

## Summary
- Sold 2,000,000 Series B Preferred shares to a single investor for aggregate $1,000; shares have $0.0001 par value.
- Each Series B share carries 10 votes, voting only on Authorized Stock Increase; no dividend or liquidation rights.
- Series B Preferred automatically redeemed for $10 upon effectiveness of Authorized Stock Increase or at board's discretion.
- Shares issued in unregistered transaction relying on Section 4(a)(2) exemption.
- Certificate of Designation filed in Nevada to create the new series.

## SEC filing metadata
- accession: 0001213900-22-068985
- form_type: 8-K
- ticker: HOTH
- cik: 0001711786
- company_name: Hoth Therapeutics, Inc.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711786/000121390022068985/0001213900-22-068985-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711786/000121390022068985/ea167990-8k_hoththera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-068985
- JSON: https://secwatch.observer/filing/0001213900-22-068985.json
- Plain text: https://secwatch.observer/filing/0001213900-22-068985.txt

## Key facts
- Governance Changes
  Hoth Therapeutics, Inc.: Created Series B Preferred Stock, designating 2,000,000 shares (effective 2022-11-02).
  - Change: charter amendment
  - Effective: 2022-11-02
  source text: On November 2, 2022, the Company filed a Certificate of Designation of the Series B Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Nevada to create a new class of Series B Preferred Stock, par value $0.0001 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1711786/000121390022068985/0001213900-22-068985-index.htm
- Material Agreements
  Hoth Therapeutics, Inc. entered into Subscription Agreement with an investor valued at $1,000 (effective 2022-11-02).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: an investor
  - Value: $1,000
  - Effective: 2022-11-02
  source text: On November 2, 2022, Hoth Therapeutics, Inc. (the “Company”) entered into a Subscription and Investment Representation Agreement (the “Subscription Agreement”) with an investor (the “Purchaser”) pursuant to which it issued and sold 2,000,000 shares (the “Shares”) of the Company’s newly designated Series B Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”), to such Purchaser for an aggregate purchase price of $1,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1711786/000121390022068985/0001213900-22-068985-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.